Current clinical applications of in vivo gene therapy with AAVs

JR Mendell, SA Al-Zaidy, LR Rodino-Klapac… - Molecular Therapy, 2021 - cell.com
Hereditary diseases are caused by mutations in genes, and more than 7,000 rare diseases
affect over 30 million Americans. For more than 30 years, hundreds of researchers have …

Molecular genetics and emerging therapies for retinitis pigmentosa: Basic research and clinical perspectives

MF Dias, K Joo, JA Kemp, SL Fialho… - Progress in retinal and …, 2018 - Elsevier
Retinitis Pigmentosa (RP) is a hereditary retinopathy that affects about 2.5 million people
worldwide. It is characterized with progressive loss of rods and cones and causes severe …

AAV-mediated gene therapy for research and therapeutic purposes

RJ Samulski, N Muzyczka - Annual review of virology, 2014 - annualreviews.org
Adeno-associated virus (AAV) is a small, nonenveloped virus that was adapted 30 years
ago for use as a gene transfer vehicle. It is capable of transducing a wide range of species …

[HTML][HTML] Progresses towards safe and efficient gene therapy vectors

S Chira, CS Jackson, I Oprea, F Ozturk, MS Pepper… - Oncotarget, 2015 - ncbi.nlm.nih.gov
The emergence of genetic engineering at the beginning of the 1970′ s opened the era of
biomedical technologies, which aims to improve human health using genetic manipulation …

An update on gene therapy for inherited retinal dystrophy: experience in Leber congenital amaurosis clinical trials

W Chiu, TY Lin, YC Chang… - International journal of …, 2021 - mdpi.com
Inherited retinal dystrophies (IRDs) are a group of rare eye diseases caused by gene
mutations that result in the degradation of cone and rod photoreceptors or the retinal …

In vitro and in vivo rescue of aberrant splicing in CEP290-associated LCA by antisense oligonucleotide delivery

A Garanto, DC Chung, L Duijkers… - Human molecular …, 2016 - academic.oup.com
Leber congenital amaurosis (LCA) is a severe disorder resulting in visual impairment
usually starting in the first year of life. The most frequent genetic cause of LCA is an intronic …

Restoring vision to the blind with chemical photoswitches

I Tochitsky, MA Kienzler, E Isacoff, RH Kramer - Chemical reviews, 2018 - ACS Publications
Degenerative retinal diseases such as retinitis pigmentosa (RP) and age-related macular
degeneration (AMD) affect millions of people around the world and lead to irreversible vision …

Red‐shifted channelrhodopsin stimulation restores light responses in blind mice, macaque retina, and human retina

A Sengupta, A Chaffiol, E Macé, R Caplette… - EMBO molecular …, 2016 - embopress.org
Targeting the photosensitive ion channel channelrhodopsin‐2 (ChR2) to the retinal circuitry
downstream of photoreceptors holds promise in treating vision loss caused by retinal …

Vector platforms for gene therapy of inherited retinopathies

I Trapani, A Puppo, A Auricchio - Progress in retinal and eye research, 2014 - Elsevier
Inherited retinopathies (IR) are common untreatable blinding conditions. Most of them are
inherited as monogenic disorders, due to mutations in genes expressed in retinal …

Targeting channelrhodopsin-2 to ON-bipolar cells with vitreally administered AAV restores ON and OFF visual responses in blind mice

E Macé, R Caplette, O Marre, A Sengupta, A Chaffiol… - Molecular Therapy, 2015 - cell.com
Most inherited retinal dystrophies display progressive photoreceptor cell degeneration
leading to severe visual impairment. Optogenetic reactivation of retinal neurons mediated by …